查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574056

活細胞成像的全球市場:2024-2034年

Live Cell Imaging Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 287 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2034 年，全球活細胞成像市場規模將以 11.7% 的複合年增長率成長。

顯微鏡技術的進步推動市場成長

近年來，共聚焦顯微鏡、多光子顯微鏡和超解析度顯微鏡等顯微鏡技術的創新徹底改變了活細胞成像的格局，使科學家能夠以前所未有的清晰度和精度更深入地研究細胞過程的動態。共焦顯微鏡的特點是使用針孔選擇性地去除離焦光，從而使標本內的薄光學切片影像更清晰。與傳統的寬視野顯微鏡相比，該技術具有更高的分辨率和對比度以及最小的光損傷，是活細胞成像的理想選擇。研究人員可以即時視覺化複雜的細胞結構和動態事件，這對於研究細胞分裂、遷移以及與微環境相互作用等過程至關重要。

設備和維護成本高昂可能會阻礙成長

與先進成像系統（例如共焦和超解析度顯微鏡設定）相關的高成本是一個重大挑戰，特別是對於預算有限的小型實驗室和研究機構而言。首先，購買這些先進成像系統所需的初始資本投資是巨大的。例如，共焦顯微鏡的價格可能從數十萬到數百萬美元不等，具體取決於所需的規格和功能。這些費用往往超出小型實驗室的預算，並使他們無法獲得尖端研究所必需的影像工具。維護成本增加了更多的經濟負擔。先進的成像系統需要定期維護、校準和偶爾維修，以確保最佳性能。

本報告提供全球活細胞成像的市場調查，彙整市場概要，影響市場成長因素及市場機會分析，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場概要

  • 主要調查結果
  • 市場動態
  • 影響分析
    • 市場推動要素
    • 阻礙市場要素
    • 市場機會
  • 供應鏈分析
  • 法律規範
  • 新興市場與大趨勢
  • 波特的五力分析
  • PEST分析

第4章 活細胞成像市場分析:各技術

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 設備
  • 消耗品
  • 軟體
  • 服務
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第5章 活細胞成像市場分析:各技術

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 光退色後螢光復甦 (FRAP)
  • 螢光共鳴能源移動 (FRET)
  • 高內涵篩選 (HCS)
  • 活細胞螢光顯微鏡
  • 其他
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第6章 活細胞成像市場分析:各用途

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 細胞生物學
  • 幹細胞
  • 藥物研發
  • 其他
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第7章 活細胞成像市場分析:各終端用戶

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 製藥·生物科技企業
  • 學術&研究機關
  • 受託研究機構 (CRO)
  • 醫院·診斷實驗室
  • 其他
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第8章 活細胞成像市場分析:各地區

  • 主要調查結果
  • 市場規模的轉變·預測

第9章 北美的活細胞成像市場分析

第10章 歐洲的活細胞成像市場分析

第11章 亞太地區的活細胞成像市場分析

第12章 南美的活細胞成像市場分析

第13章 中東·非洲的活細胞成像市場分析

第14章 企業簡介

  • 競爭情形
  • 策略性展望
  • Bio-Rad Laboratories
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • GE Healthcare Life Sciences
  • Hamamatsu Photonics K.K.
  • Leica Microsystems GmbH
  • Molecular Devices, LLC
  • NanoEnTek Inc.
  • Nikon Instruments Inc.
  • Olympus Corporation
  • Oxford Instruments PLC
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA

第15章 總論·建議

  • Visiongain的總論
  • 市場參與企業的建議
Product Code: PHA1361

The global Live Cell Imaging Market is projected to grow at a CAGR of 11.7% by 2034

The Live Cell Imaging Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Microscopy Technologies Driving Market Growth

In recent years, innovations in microscopy techniques like confocal microscopy, multiphoton microscopy, and super-resolution microscopy have transformed the landscape of live cell imaging, enabling scientists to delve deeper into the dynamics of cellular processes with unprecedented clarity and precision. Confocal microscopy stands out by using a pinhole to selectively eliminate out-of-focus light, producing sharper images of thin optical sections within a specimen. This technique enhances resolution and contrast compared to traditional widefield microscopy, making it ideal for imaging live cells with minimal photodamage. Researchers can visualize intricate cellular structures and dynamic events in real-time, crucial for studying processes such as cell division, migration, and interaction with their microenvironment.

High Cost of Equipment and Maintenance Likely to Hamper Industry Growth

The high costs associated with advanced imaging systems like confocal microscopes and super-resolution microscopy setups present significant challenges, particularly for smaller research laboratories and institutions operating within limited budgets. Firstly, the initial capital investment required to purchase these advanced imaging systems can be substantial. Confocal microscopes, for example, can cost hundreds of thousands to millions of dollars depending on the specifications and capabilities needed. This expense often exceeds the available budget of smaller labs, hindering their ability to acquire essential imaging tools for cutting-edge research. Maintenance costs further compound the financial burden. Advanced imaging systems require regular maintenance, calibration, and occasional repairs to ensure optimal performance.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the live cell imaging market evolving?
  • What is driving and restraining the live cell imaging market?
  • How will each live cell imaging submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each live cell imaging submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading live cell imaging markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the live cell imaging projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of live cell imaging projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the live cell imaging market?
  • Where is the live cell imaging market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the live cell imaging market today, and over the next 10 years:

  • Our 307-page report provides 109 tables and 186 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2034 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising live cell imaging prices and recent developments.

Segments Covered in the Report

  • Product Type
  • Instruments
  • Consumables
  • Software
  • Services
  • Technology
  • Fluorescence Recovery After Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Live Cell Fluorescence Microscopy
  • Others
  • Application
  • Cell Biology
  • Stem Cell
  • Drug Discovery
  • Others
  • End-User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Hospitals & Diagnostic Laboratories
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the Live Cell Imaging Market, 2024 to 2034, with a focus on this segment of these companies' operations.

  • Leading companies profiled in the report
  • Bio-Rad Laboratories
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • GE Healthcare Life Sciences
  • Hamamatsu Photonics K.K.
  • Leica Microsystems GmbH
  • Molecular Devices, LLC
  • NanoEnTek Inc.
  • Nikon Instruments Inc.
  • Olympus Corporation
  • Oxford Instruments PLC
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA

Overall world revenue for Live Cell Imaging Market, 2024 to 2034 in terms of value the market will surpass US$3,177.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Live Cell Imaging Market, 2024 to 2034 report help you?
  • In summary, our 307+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Live Cell Imaging Market, 2024 to 2034 Market, with forecasts for product type, technology, application, end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Live Cell Imaging Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Live Cell Imaging Market, 2024 to 2034.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Live Cell Imaging Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Live Cell Imaging Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Growing Investment from Academic Institutions and Biotechnology Companies
      • 3.3.1.2 Advancements in Microscopy Technologies
      • 3.3.1.3 Rising Demand in Drug Discovery and Development
      • 3.3.1.4 Growing Applications in Biomedical Research
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 High Cost of Equipment and Maintenance
      • 3.3.2.2 Complexity of Data Analysis
      • 3.3.2.3 Phototoxicity and Cell Viability
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Integration with Artificial Intelligence and Machine Learning
      • 3.3.3.2 Growing Demand for Affordable Imaging Systems
      • 3.3.3.3 Expansion in Drug Discovery and Personalized Medicine
  • 3.4 Supply Chain Analysis
  • 3.5 Regulatory Framework
  • 3.6 Emerging Markets and Megatrends
  • 3.7 Porter's Five Forces Analysis
    • 3.7.1 Bargaining Power of Suppliers
    • 3.7.2 Bargaining Power of Buyers
    • 3.7.3 Competitive Rivalry
    • 3.7.4 Threat of Substitutes
    • 3.7.5 Threat of New Entrants
  • 3.8 PEST Analysis

4 Live Cell Imaging Market Analysis by Product Type

  • 4.1 Key Findings
  • 4.2 Product Type Segment: Market Attractiveness Index
  • 4.3 Live Cell Imaging Market Size Estimation and Forecast by Product Type
  • 4.4 Instruments
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Consumables
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Software
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Services
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Live Cell Imaging Market Analysis by Technology

  • 5.1 Key Findings
  • 5.2 Technology Segment: Market Attractiveness Index
  • 5.3 Live Cell Imaging Market Size Estimation and Forecast by Technology
  • 5.4 Fluorescence Recovery After Photobleaching (FRAP)
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Fluorescence Resonance Energy Transfer (FRET)
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 High Content Screening (HCS)
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Live Cell Fluorescence Microscopy
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Live Cell Imaging Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
  • 6.3 Live Cell Imaging Market Size Estimation and Forecast by Application
  • 6.4 Cell Biology
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Stem Cell
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Drug Discovery
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Others
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Live Cell Imaging Market Analysis by End-User

  • 7.1 Key Findings
  • 7.2 End-User Segment: Market Attractiveness Index
  • 7.3 Live Cell Imaging Market Size Estimation and Forecast by End-User
  • 7.4 Pharmaceutical & Biotechnology Companies
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Academic & Research Institutes
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Contract Research Organizations (CROs)
    • 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)
  • 7.7 Hospitals & Diagnostic Laboratories
    • 7.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.7.2 Market Share by Region, 2024 & 2034 (%)
  • 7.8 Others
    • 7.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.8.2 Market Share by Region, 2024 & 2034 (%)

8 Live Cell Imaging Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Live Cell Imaging Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Live Cell Imaging Market Attractiveness Index
  • 9.3 North America Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 9.4 North America Live Cell Imaging Market Size Estimation and Forecast by Country
  • 9.5 North America Live Cell Imaging Market Size Estimation and Forecast by Product Type
  • 9.6 North America Live Cell Imaging Market Size Estimation and Forecast by Technology
  • 9.7 North America Live Cell Imaging Market Size Estimation and Forecast by Application
  • 9.8 North America Live Cell Imaging Market Size Estimation and Forecast by End-User
  • 9.9 U.S. Live Cell Imaging Market Analysis
  • 9.10 Canada Live Cell Imaging Market Analysis

10 Europe Live Cell Imaging Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Live Cell Imaging Market Attractiveness Index
  • 10.3 Europe Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 Europe Live Cell Imaging Market Size Estimation and Forecast by Country
  • 10.5 Europe Live Cell Imaging Market Size Estimation and Forecast by Product Type
  • 10.6 Europe Live Cell Imaging Market Size Estimation and Forecast by Technology
  • 10.7 Europe Live Cell Imaging Market Size Estimation and Forecast by Application
  • 10.8 Europe Live Cell Imaging Market Size Estimation and Forecast by End-User
  • 10.9 Germany Live Cell Imaging Market Analysis
  • 10.10 France Live Cell Imaging Market Analysis
  • 10.11 UK Live Cell Imaging Market Analysis
  • 10.12 Italy Live Cell Imaging Market Analysis
  • 10.13 Spain Live Cell Imaging Market Analysis
  • 10.14 Russia Live Cell Imaging Market Analysis
  • 10.15 Rest of Europe Live Cell Imaging Market Analysis

11 Asia Pacific Live Cell Imaging Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Live Cell Imaging Market Attractiveness Index
  • 11.3 Asia Pacific Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Product Type
  • 11.6 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Technology
  • 11.7 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Application
  • 11.8 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by End-User
  • 11.9 Japan Live Cell Imaging Market Analysis
  • 11.10 China Live Cell Imaging Market Analysis
  • 11.11 India Live Cell Imaging Market Analysis
  • 11.12 Australia Live Cell Imaging Market Analysis
  • 11.13 South Korea Live Cell Imaging Market Analysis
  • 11.14 Singapore Live Cell Imaging Market Analysis
  • 11.15 Rest of Asia Pacific Live Cell Imaging Market Analysis

12 Latin America Live Cell Imaging Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Live Cell Imaging Market Attractiveness Index
  • 12.3 Latin America Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 Latin America Live Cell Imaging Market Size Estimation and Forecast by Country
  • 12.5 Latin America Live Cell Imaging Market Size Estimation and Forecast by Product Type
  • 12.6 Latin America Live Cell Imaging Market Size Estimation and Forecast by Technology
  • 12.7 Latin America Live Cell Imaging Market Size Estimation and Forecast by Application
  • 12.8 Latin America Live Cell Imaging Market Size Estimation and Forecast by End-User
  • 12.9 Brazil Live Cell Imaging Market Analysis
  • 12.10 Mexico Live Cell Imaging Market Analysis
  • 12.11 Argentina Live Cell Imaging Market Analysis
  • 12.12 Colombia Live Cell Imaging Market Analysis
  • 12.13 Rest of Latin America Live Cell Imaging Market Analysis

13 MEA Live Cell Imaging Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Live Cell Imaging Market Attractiveness Index
  • 13.3 MEA Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 13.4 MEA Live Cell Imaging Market Size Estimation and Forecast by Country
  • 13.5 MEA Live Cell Imaging Market Size Estimation and Forecast by Product Type
  • 13.6 MEA Live Cell Imaging Market Size Estimation and Forecast by Technology
  • 13.7 MEA Live Cell Imaging Market Size Estimation and Forecast by Application
  • 13.8 MEA Live Cell Imaging Market Size Estimation and Forecast by End-User
  • 13.9 GCC Live Cell Imaging Market Analysis
  • 13.10 South Africa Live Cell Imaging Market Analysis
  • 13.11 Rest of MEA Live Cell Imaging Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2023
  • 14.2 Strategic Outlook
  • 14.3 Bio-Rad Laboratories
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2018-2023
      • 14.3.3.2 Gross Profit, 2018-2023
      • 14.3.3.3 R&D, 2017-2022
    • 14.3.4 Product Benchmarking
    • 14.3.5 SWOT Analysis
  • 14.4 BioTek Instruments, Inc.
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Product Benchmarking
    • 14.4.4 SWOT Analysis
  • 14.5 Bruker Corporation
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2018-2023
      • 14.5.3.2 Gross Profit, 2018-2023
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
    • 14.5.6 SWOT Analysis
  • 14.6 Carl Zeiss AG
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2018-2023
    • 14.6.4 Product Benchmarking
    • 14.6.5 SWOT Analysis
  • 14.7 GE Healthcare Life Sciences
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2018-2023
      • 14.7.3.2 Gross Profit, 2018-2023
      • 14.7.3.3 R&D, 2018-2023
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
    • 14.7.6 SWOT Analysis
  • 14.8 Hamamatsu Photonics K.K.
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020-2023
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
    • 14.8.6 SWOT Analysis
  • 14.9 Leica Microsystems GmbH
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Product Benchmarking
    • 14.9.4 Strategic Outlook
    • 14.9.5 SWOT Analysis
  • 14.10 Molecular Devices, LLC
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Product Benchmarking
    • 14.10.4 SWOT Analysis
  • 14.11 NanoEnTek Inc.
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Product Benchmarking
    • 14.11.4 SWOT Analysis
  • 14.12 Nikon Instruments Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2018-2023
      • 14.12.3.2 Gross Profit, 2018-2023
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
    • 14.12.6 SWOT Analysis
  • 14.13 Olympus Corporation
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2018-2022
      • 14.13.3.2 Gross Profit, 2018-2022
    • 14.13.4 Product Benchmarking
    • 14.13.5 SWOT Analysis
  • 14.14 Oxford Instruments PLC
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2018-2022
    • 14.14.4 Product Benchmarking
    • 14.14.5 SWOT Analysis
  • 14.15 PerkinElmer Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2018-2023
      • 14.15.3.2 Gross Profit, 2018-2023
      • 14.15.3.3 R&D Expense, 2018-2023
    • 14.15.4 Product Benchmarking
    • 14.15.5 SWOT Analysis
  • 14.16 Thermo Fisher Scientific Inc.
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
      • 14.16.3.1 Net Revenue, 2018-2023
      • 14.16.3.2 Gross Profit, 2018-2023
      • 14.16.3.3 R&D, 2018-2023
    • 14.16.4 Product Benchmarking
    • 14.16.5 SWOT Analysis
  • 14.17 Merck KGaA
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Financial Analysis
      • 14.17.3.1 Net Revenue, 2018-2023
      • 14.17.3.2 Gross Profit, 2018-2023
      • 14.17.3.3 R&D Expense, 2018-2023
    • 14.17.4 Product Benchmarking
    • 14.17.5 SWOT Analysis

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Live Cell Imaging Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 3 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 4 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 5 Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 6 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 7 Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 Fluorescence Recovery After Photobleaching (FRAP) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 Fluorescence Resonance Energy Transfer (FRET) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 High Content Screening (HCS) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Live Cell Fluorescence Microscopy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Cell Biology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Stem Cell Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Drug Discovery Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Hospitals & Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Live Cell Imaging Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 North America Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 26 North America Live Cell Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 North America Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 North America Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 North America Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 30 U.S. Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 Canada Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 Europe Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 Europe Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 Europe Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 Europe Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 Europe Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 Germany Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 France Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 UK Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Italy Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Spain Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 Russia Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Rest of Europe Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 Asia Pacific Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 Asia Pacific Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 Asia Pacific Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 47 Asia Pacific Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Asia Pacific Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Japan Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 China Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 India Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Australia Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 South Korea Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 Singapore Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Rest of Asia Pacific Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 Latin America Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Latin America Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Latin America Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Latin America Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Latin America Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 Brazil Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Mexico Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 Argentina Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 Colombia Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Rest of Latin America Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 66 MEA Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 MEA Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 MEA Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 MEA Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 MEA Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 GCC Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 South Africa Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 73 Rest of MEA Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 Strategic Outlook
  • Table 75 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Bio-Rad Laboratories: Product Benchmarking
  • Table 77 BioTek Instruments, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 78 BioTek Instruments, Inc.: Product Benchmarking
  • Table 79 Bruker Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 Bruker Corporation: Product Benchmarking
  • Table 81 Bruker Corporation: Strategic Outlook
  • Table 82 Carl Zeiss AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 Carl Zeiss AG: Product Benchmarking
  • Table 84 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 GE Healthcare Life Sciences: Product Benchmarking
  • Table 86 GE Healthcare Life Sciences: Strategic Outlook
  • Table 87 Hamamatsu Photonics K.K.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Hamamatsu Photonics K.K.: Product Benchmarking
  • Table 89 Hamamatsu Photonics K.K.: Strategic Outlook
  • Table 90 Leica Microsystems GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Leica Microsystems GmbH: Product Benchmarking
  • Table 92 Leica Microsystems GmbH: Strategic Outlook
  • Table 93 Molecular Devices, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Molecular Devices, LLC: Product Benchmarking
  • Table 95 NanoEnTek Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 NanoEnTek Inc.: Product Benchmarking
  • Table 97 Nikon Instruments Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Nikon Instruments Inc.: Product Benchmarking
  • Table 99 Nikon Instruments Inc.: Strategic Outlook
  • Table 100 Olympus Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Olympus Corporation: Product Benchmarking
  • Table 102 Oxford Instruments PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Oxford Instruments PLC: Product Benchmarking
  • Table 104 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 PerkinElmer Inc.: Product Benchmarking
  • Table 106 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 108 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Merck KGaA: Product Benchmarking

List of Figures

  • Figure 1 Live Cell Imaging Market Segmentation
  • Figure 2 Live Cell Imaging Market by Product Type: Market Attractiveness Index
  • Figure 3 Live Cell Imaging Market by Technology: Market Attractiveness Index
  • Figure 4 Live Cell Imaging Market by Application: Market Attractiveness Index
  • Figure 5 Live Cell Imaging Market by End-User: Market Attractiveness Index
  • Figure 6 Live Cell Imaging Market Attractiveness Index by Region
  • Figure 7 Live Cell Imaging Market: Market Dynamics
  • Figure 8 Live Cell Imaging Market: Impact Analysis
  • Figure 9 Live Cell Imaging Market: Supply Chain Analysis
  • Figure 10 Live Cell Imaging Market: Porter's Five Forces Analysis
  • Figure 11 Live Cell Imaging Market: PEST Analysis
  • Figure 12 Live Cell Imaging Market by Product Type: Market Attractiveness Index
  • Figure 13 Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR %)
  • Figure 14 Live Cell Imaging Market Share Forecast by Product Type, 2024, 2029, 2034 (%)
  • Figure 15 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 16 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 17 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 18 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 20 Software Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 22 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Live Cell Imaging Market by Technology: Market Attractiveness Index
  • Figure 24 Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 25 Live Cell Imaging Market Share Forecast by Technology, 2024, 2029, 2034 (%)
  • Figure 26 Fluorescence Recovery After Photobleaching (FRAP) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 27 Fluorescence Recovery After Photobleaching (FRAP) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 28 Fluorescence Resonance Energy Transfer (FRET) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 29 Fluorescence Resonance Energy Transfer (FRET) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 High Content Screening (HCS) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 31 High Content Screening (HCS) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 Live Cell Fluorescence Microscopy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 33 Live Cell Fluorescence Microscopy Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 35 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Live Cell Imaging Market by Application: Market Attractiveness Index
  • Figure 37 Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 38 Live Cell Imaging Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 39 Cell Biology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 40 Cell Biology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Stem Cell Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 42 Stem Cell Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Drug Discovery Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 44 Drug Discovery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 46 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Live Cell Imaging Market by End-User: Market Attractiveness Index
  • Figure 48 Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR %)
  • Figure 49 Live Cell Imaging Market Share Forecast by End-User, 2024, 2029, 2034 (%)
  • Figure 50 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 51 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 52 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 53 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 55 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 56 Hospitals & Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 57 Hospitals & Diagnostic Laboratories Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 58 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 59 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 60 Live Cell Imaging Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
  • Figure 61 Live Cell Imaging Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 62 Live Cell Imaging Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 63 North America Live Cell Imaging Market Attractiveness Index
  • Figure 64 North America Live Cell Imaging Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 65 North America Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 66 North America Live Cell Imaging Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 67 North America Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR %)
  • Figure 68 North America Live Cell Imaging Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 69 North America Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 70 North America Live Cell Imaging Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 71 North America Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 72 North America Live Cell Imaging Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 73 North America Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR %)
  • Figure 74 North America Live Cell Imaging Market Share Forecast by End-User, 2024 & 2034 (%)
  • Figure 75 U.S. Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 76 Canada Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 77 Europe Live Cell Imaging Market Attractiveness Index
  • Figure 78 Europe Live Cell Imaging Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 79 Europe Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 80 Europe Live Cell Imaging Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 81 Europe Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR %)
  • Figure 82 Europe Live Cell Imaging Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 83 Europe Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 84 Europe Live Cell Imaging Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 85 Europe Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 86 Europe Live Cell Imaging Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 87 Europe Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR %)
  • Figure 88 Europe Live Cell Imaging Market Share Forecast by End-User, 2024 & 2034 (%)
  • Figure 89 Germany Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 90 France Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 91 UK Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 92 Italy Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 93 Spain Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 94 Russia Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 95 Rest of Europe Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 96 Asia Pacific Live Cell Imaging Market Attractiveness Index
  • Figure 97 Asia Pacific Live Cell Imaging Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 98 Asia Pacific Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 99 Asia Pacific Live Cell Imaging Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 100 Asia Pacific Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Asia Pacific Live Cell Imaging Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 102 Asia Pacific Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 103 Asia Pacific Live Cell Imaging Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 104 Asia Pacific Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 105 Asia Pacific Live Cell Imaging Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 106 Asia Pacific Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR %)
  • Figure 107 Asia Pacific Live Cell Imaging Market Share Forecast by End-User, 2024 & 2034 (%)
  • Figure 108 Japan Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 109 China Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 110 India Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 111 Australia Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 112 South Korea Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 113 Singapore Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 114 Rest of Asia Pacific Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 115 Latin America Live Cell Imaging Market Attractiveness Index
  • Figure 116 Latin America Live Cell Imaging Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 117 Latin America Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 118 Latin America Live Cell Imaging Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 119 Latin America Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR %)
  • Figure 120 Latin America Live Cell Imaging Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 121 Latin America Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 122 Latin America Live Cell Imaging Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 123 Latin America Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 124 Latin America Live Cell Imaging Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 125 Latin America Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR %)
  • Figure 126 Latin America Live Cell Imaging Market Share Forecast by End-User, 2024 & 2034 (%)
  • Figure 127 Brazil Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 128 Mexico Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 129 Argentina Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 130 Colombia Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 131 Rest of Latin America Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 132 MEA Live Cell Imaging Market Attractiveness Index
  • Figure 133 MEA Live Cell Imaging Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 134 MEA Live Cell Imaging Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 135 MEA Live Cell Imaging Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 136 MEA Live Cell Imaging Market Forecast by Product Type, 2024-2034 (US$ Million, AGR %)
  • Figure 137 MEA Live Cell Imaging Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 138 MEA Live Cell Imaging Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 139 MEA Live Cell Imaging Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 140 MEA Live Cell Imaging Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 141 MEA Live Cell Imaging Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 142 MEA Live Cell Imaging Market Forecast by End-User, 2024-2034 (US$ Million, AGR %)
  • Figure 143 MEA Live Cell Imaging Market Share Forecast by End-User, 2024 & 2034 (%)
  • Figure 144 GCC Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 145 South Africa Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 146 Rest of MEA Live Cell Imaging Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 147 Live Cell Imaging Market: Company Share/Ranking, 2023
  • Figure 148 Bio-Rad Laboratories: Net Revenue, 2018-2023 (US$ Million, AGR %)
  • Figure 149 Bio-Rad Laboratories: Gross Profit, 2018-2023 (US$ Million, AGR %)
  • Figure 150 Bio-Rad Laboratories: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 151 Bio-Rad Laboratories: SWOT Analysis
  • Figure 152 BioTek Instruments, Inc.: SWOT Analysis
  • Figure 153 Bruker Corporation: Net Revenue, 2018-2023 (US$ Million, AGR %)
  • Figure 154 Bruker Corporation: Gross Profit, 2018-2023 (US$ Million, AGR %)
  • Figure 155 Bruker Corporation: SWOT Analysis
  • Figure 156 Carl Zeiss AG: Net Revenue, 2018-2023 (US$ Million, AGR %)
  • Figure 157 Carl Zeiss AG: SWOT Analysis
  • Figure 158 GE Healthcare: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 159 GE Healthcare: Gross Profit, 2018-2023 (US$ Million, AGR%)
  • Figure 160 GE Healthcare: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 161 GE Healthcare Life Sciences: SWOT Analysis
  • Figure 162 Hamamatsu Photonics K.K.: Net Revenue, 2020-2023 (US$ Million, AGR %)
  • Figure 163 Hamamatsu Photonics K.K.: SWOT Analysis
  • Figure 164 Leica Microsystems GmbH: SWOT Analysis
  • Figure 165 Molecular Devices, LLC: SWOT Analysis
  • Figure 166 NanoEnTek Inc.: SWOT Analysis
  • Figure 167 Nikon Instruments Inc.: Net Revenue, 2018-2023 (US$ Million, AGR %)
  • Figure 168 Nikon Instruments Inc.: Gross Profit, 2018-2023 (US$ Million, AGR %)
  • Figure 169 Nikon Instruments Inc.: SWOT Analysis
  • Figure 170 Olympus Corporation: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 171 Olympus Corporation: Gross Profit, 2018-2022 (US$ Million, AGR %)
  • Figure 172 Olympus Corporation: SWOT Analysis
  • Figure 173 Oxford Instruments PLC: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 174 Oxford Instruments PLC: SWOT Analysis
  • Figure 175 PerkinElmer Inc.: Net Revenue, 2018-2023 (US$ Million, AGR %)
  • Figure 176 PerkinElmer Inc.: Gross Profit, 2018-2023 (US$ Million, AGR %)
  • Figure 177 PerkinElmer Inc.: R&D Expense, 2018-2023 (US$ Million, AGR %)
  • Figure 178 PerkinElmer Inc.: SWOT Analysis
  • Figure 179 Thermo Fisher Scientific Inc.: Net Revenue, 2018-2023 (US$ Million, AGR %)
  • Figure 180 Thermo Fisher Scientific Inc.: Gross Profit, 2018-2023 (US$ Million, AGR %)
  • Figure 181 Thermo Fisher Scientific Inc.: R&D, 2018-2023 (US$ Million, AGR %)
  • Figure 182 Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 183 Merck KGaA: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 184 Merck KGaA: Gross Profit, 2018-2023 (US$ Million, AGR%)
  • Figure 185 Merck KGaA: R&D Expense, 2018-2023 (US$ Million, AGR%)
  • Figure 186 Merck KGaA: SWOT Analysis